Julien A. Perez

Dirigeant – Démarche Française 🇫🇷 | Titres de séjour & naturalisation 🪪⚠️ Des erreurs qui coûtent des années ⏳

📍 France🔄 Updated September 2026💼 1 investments📅 2 years investing🗓 Last invested May 2024
Operator-angel🌍 France
1
Total investments
0
Early stage
1
Mid stage
0
Late stage
2y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investisseur
May 2024
Ziwig Biotech is a biotechnology company pioneering the analysis of salivary RNA and the application of artificial intelligence to biomolecular biology. At the crossroads of medicine, data science, and digital technology, Ziwig develops non-invasive tests and therapeutic biomarkers designed to transform the diagnosis and management of chronic diseases—particularly those affecting women. Its flagship innovation, Endotest®, is the first non-invasive and highly reliable saliva-based test for the diagnosis of endometriosis. This breakthrough innovation, multiple award-winner (Galien Prize, Tech For Future Award), exemplifies Ziwig’s ability to revolutionize women’s health through the convergence of biotechnology, artificial intelligence, and precision medicine. Ziwig operates at the heart of a rapidly evolving global health ecosystem, where universal access to diagnosis and prevention is a major challenge for equity and sustainability. Through its scientific and societal commitment, Ziwig contributes to building a more human, accessible, and universal precision medicine—serving patients, healthcare professionals, and the health systems of the future. 🌐 www.ziwig.com
Experience · 3 entries
All (3)
Investments (1)
Founder (2)
2024
Investisseur
May 2024
Ziwig Biotech is a biotechnology company pioneering the analysis of salivary RNA and the application of artificial intelligence to biomolecular biology. At the crossroads of medicine, data science, and digital technology, Ziwig develops non-invasive tests and therapeutic biomarkers designed to transform the diagnosis and management of chronic diseases—particularly those affecting women. Its flagship innovation, Endotest®, is the first non-invasive and highly reliable saliva-based test for the diagnosis of endometriosis. This breakthrough innovation, multiple award-winner (Galien Prize, Tech For Future Award), exemplifies Ziwig’s ability to revolutionize women’s health through the convergence of biotechnology, artificial intelligence, and precision medicine. Ziwig operates at the heart of a rapidly evolving global health ecosystem, where universal access to diagnosis and prevention is a major challenge for equity and sustainability. Through its scientific and societal commitment, Ziwig contributes to building a more human, accessible, and universal precision medicine—serving patients, healthcare professionals, and the health systems of the future. 🌐 www.ziwig.com
2023
Co-fondateur
Aug 2023
Mazao Immobilier est une agence spécialisée dans la vente et la location de biens immobiliers à Paris et en proche banlieue.